Agnieszka Harazin-Lechowska

Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signatures

Sultana Mehbuba Hossain, Grégory Gimenez, Peter A. Stockwell et al. · Frontiers in Immunology · 2022 · 36 citations · Full text

Melanoma Tissues, Immunology, Immunoediting +18

Original paper Prognostic value of PIK3CA mutation status, PTEN and androgen receptor expression for metastasis-free survival in HER2-positive breast cancer patients treated with trastuzumab in adjuvant setting

Agnieszka Adamczyk, Joanna Niemiec, Anna Janecka et al. · Polish Journal of Pathology · 2015 · 25 citations · Full text

Specificity and sensitivity of INI-1 labeling in epithelioid sarcoma. Loss of INI1 expression as a frequent immunohistochemical event in synovial sarcoma Loss of INI1 expression as a frequent immunohistochemical event in synovial sarcoma

Katarzyna Mularz, Agnieszka Harazin-Lechowska, Aleksandra Ambicka et al. · Polish Journal of Pathology · 2012 · 24 citations · Full text

Synovial Sarcoma Loss, Immunology, Pathology +16

Effect of Changes in Finger Skin Temperature on Vibrotactile Perception Threshold

Barbara Harazin, Agnieszka Harazin-Lechowska · International Journal of Occupational Medicine and Environmental Health · 2007 · 23 citations

Relationship between <em>HER2</em> gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment

Agnieszka Adamczyk, Anna Kruczak, Agnieszka Harazin-Lechowska et al. · OncoTargets and Therapy · 2018 · 23 citations · Full text